Identification and mapping of genes in the AD region on CH 15q11-13

S. J. Kim, M. M. Menold, L. Zaeem, M. P. Bass, Jeffery M Vance, Margaret A Pericak-Vance, John Gilbert

Research output: Contribution to journalArticle

Abstract

Chromosome 15q11-q13 is implicated in the genetic etiology of Autistic Disorder (AD) based on:1) cytogenetic abnormalities; 2) suggested linkage with chromosome 15 markers; 3) association with polymorphisms in the g-aminobutyric acid receptor subunit B3 gene (GABRB3); and 4) increased recombination frequency in this region in AD versus control families. To isolate the 15q11-q13 AD gene, a genomic contig and physical map of the 1-1.5 Mb region from the GABRB3 receptor to the OCA2 gene was generated. Not I and numerous Eag I restriction enzyme sites, frequently found in CpG islands associated with promoter and initiation sites at the 50 end of genes, were identified in this region. To begin identification of additional AD candidate genes within the contig, ten regions containing Not I and Eag I sites that have the characteristics of CpG islands have been cloned and sequenced. Sequence data has allowed the mapping of at least one known, but previously unmapped, gene to the region. The isolation of additional CpG islands is in progress. Putative coding sequences from islands are being tested using northern blots. These studies will identify and map candidate genes and allow the investigation of the methylation status of CpG islands in tissues.

Original languageEnglish
JournalAmerican Journal of Medical Genetics - Neuropsychiatric Genetics
Volume96
Issue number4
StatePublished - Aug 7 2000
Externally publishedYes

Fingerprint

Chromosome Mapping
Autistic Disorder
CpG Islands
Genes
Aminobutyrates
Chromosomes, Human, Pair 15
Genetic Markers
Islands
Chromosome Aberrations
Northern Blotting
Methylation
Genetic Recombination
Chromosomes
Enzymes

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)

Cite this

Identification and mapping of genes in the AD region on CH 15q11-13. / Kim, S. J.; Menold, M. M.; Zaeem, L.; Bass, M. P.; Vance, Jeffery M; Pericak-Vance, Margaret A; Gilbert, John.

In: American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 96, No. 4, 07.08.2000.

Research output: Contribution to journalArticle

@article{b4901bfc0de14adf8fd3c5cc0078e7c6,
title = "Identification and mapping of genes in the AD region on CH 15q11-13",
abstract = "Chromosome 15q11-q13 is implicated in the genetic etiology of Autistic Disorder (AD) based on:1) cytogenetic abnormalities; 2) suggested linkage with chromosome 15 markers; 3) association with polymorphisms in the g-aminobutyric acid receptor subunit B3 gene (GABRB3); and 4) increased recombination frequency in this region in AD versus control families. To isolate the 15q11-q13 AD gene, a genomic contig and physical map of the 1-1.5 Mb region from the GABRB3 receptor to the OCA2 gene was generated. Not I and numerous Eag I restriction enzyme sites, frequently found in CpG islands associated with promoter and initiation sites at the 50 end of genes, were identified in this region. To begin identification of additional AD candidate genes within the contig, ten regions containing Not I and Eag I sites that have the characteristics of CpG islands have been cloned and sequenced. Sequence data has allowed the mapping of at least one known, but previously unmapped, gene to the region. The isolation of additional CpG islands is in progress. Putative coding sequences from islands are being tested using northern blots. These studies will identify and map candidate genes and allow the investigation of the methylation status of CpG islands in tissues.",
author = "Kim, {S. J.} and Menold, {M. M.} and L. Zaeem and Bass, {M. P.} and Vance, {Jeffery M} and Pericak-Vance, {Margaret A} and John Gilbert",
year = "2000",
month = "8",
day = "7",
language = "English",
volume = "96",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Identification and mapping of genes in the AD region on CH 15q11-13

AU - Kim, S. J.

AU - Menold, M. M.

AU - Zaeem, L.

AU - Bass, M. P.

AU - Vance, Jeffery M

AU - Pericak-Vance, Margaret A

AU - Gilbert, John

PY - 2000/8/7

Y1 - 2000/8/7

N2 - Chromosome 15q11-q13 is implicated in the genetic etiology of Autistic Disorder (AD) based on:1) cytogenetic abnormalities; 2) suggested linkage with chromosome 15 markers; 3) association with polymorphisms in the g-aminobutyric acid receptor subunit B3 gene (GABRB3); and 4) increased recombination frequency in this region in AD versus control families. To isolate the 15q11-q13 AD gene, a genomic contig and physical map of the 1-1.5 Mb region from the GABRB3 receptor to the OCA2 gene was generated. Not I and numerous Eag I restriction enzyme sites, frequently found in CpG islands associated with promoter and initiation sites at the 50 end of genes, were identified in this region. To begin identification of additional AD candidate genes within the contig, ten regions containing Not I and Eag I sites that have the characteristics of CpG islands have been cloned and sequenced. Sequence data has allowed the mapping of at least one known, but previously unmapped, gene to the region. The isolation of additional CpG islands is in progress. Putative coding sequences from islands are being tested using northern blots. These studies will identify and map candidate genes and allow the investigation of the methylation status of CpG islands in tissues.

AB - Chromosome 15q11-q13 is implicated in the genetic etiology of Autistic Disorder (AD) based on:1) cytogenetic abnormalities; 2) suggested linkage with chromosome 15 markers; 3) association with polymorphisms in the g-aminobutyric acid receptor subunit B3 gene (GABRB3); and 4) increased recombination frequency in this region in AD versus control families. To isolate the 15q11-q13 AD gene, a genomic contig and physical map of the 1-1.5 Mb region from the GABRB3 receptor to the OCA2 gene was generated. Not I and numerous Eag I restriction enzyme sites, frequently found in CpG islands associated with promoter and initiation sites at the 50 end of genes, were identified in this region. To begin identification of additional AD candidate genes within the contig, ten regions containing Not I and Eag I sites that have the characteristics of CpG islands have been cloned and sequenced. Sequence data has allowed the mapping of at least one known, but previously unmapped, gene to the region. The isolation of additional CpG islands is in progress. Putative coding sequences from islands are being tested using northern blots. These studies will identify and map candidate genes and allow the investigation of the methylation status of CpG islands in tissues.

UR - http://www.scopus.com/inward/record.url?scp=33749115130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749115130&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749115130

VL - 96

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 4

ER -